PLA2G16 anticorps (AA 12-132)
Aperçu rapide pour PLA2G16 anticorps (AA 12-132) (ABIN2336624)
Antigène
Voir toutes PLA2G16 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 12-132
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- PLA2G16 (Group XVI Phospholipase A2, Adipose-specific Phospholipase A2, AdPLA, H-rev 107 Protein Homolog, HRAS-like Suppressor 3, HREV107, HREV107-3, Renal Carcinoma Antigen NY-REN-65, HRASLS3)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- Purified, E.coli-derived recombinant human PLA2G16. (Asp12-Asp132, Accession #P53816).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitute in 100 μL sterile water.
-
Buffer
- Supplied as a lyophilized powder from a 0.2um filtered solution in PBS, 5 % trehalose.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))
-
Autre désignation
- PLA2G16
-
UniProt
- P53816
-
Pathways
- Inositol Metabolic Process
Antigène
-